Learning from Adaptations to the COVID-19 Pandemic: How Teleconsultation Supported Cancer Care Pathways at a Comprehensive Cancer Center in Northern Italy.
COVID-19
cancer care pathway
multidisciplinary team meeting
oncology
teleconsultation
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
26 Apr 2023
26 Apr 2023
Historique:
received:
05
04
2023
revised:
21
04
2023
accepted:
24
04
2023
medline:
13
5
2023
pubmed:
13
5
2023
entrez:
13
5
2023
Statut:
epublish
Résumé
Multidisciplinary team (MDT) meetings are recognized as the gold standard for care management of cancer patients, and during the COVID-19 pandemic they were considered a priority to be maintained. Due to pandemic-related restrictions, MDT meetings were forcibly converted from in-person to telematic format. This retrospective study evaluated the annual performance of four MDT meeting indicators (MDT members' attendance, number of discussed cases, frequency of MDT meetings, and duration) between 2019 and 2022 to report on the implementation of teleconsultation in MDT meetings related to 10 cancer care pathways (CCPs). Over the study period, MDT member participation and the number of discussed cases improved or did not change in 90% (9/10) and 80% (8/10) of the CCPs, respectively. We did not observe significant differences in any of the CCPs included in the study regarding the annual frequency and duration of MDT meeting. Considering the rapidity, extent, and intensity with which telematic tools were adopted due to the COVID-19 pandemic, the results of this study showed that MDT teleconsultation supported the CCPs, and consequently, the delivery of cancer care in COVID-19 times, helping to understand the effects of telematic tools on health care performance and the parties involved.
Identifiants
pubmed: 37173952
pii: cancers15092486
doi: 10.3390/cancers15092486
pmc: PMC10177335
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Surg Oncol. 2017 Sep;24(9):2669-2678
pubmed: 28337661
Oncologist. 2021 Apr;26(4):e679-e685
pubmed: 33453121
Clin Transl Oncol. 2021 Aug;23(8):1611-1619
pubmed: 33650029
Nutr Cancer. 2023;75(1):197-206
pubmed: 35903847
Cancers (Basel). 2022 Feb 23;14(5):
pubmed: 35267437
BMC Health Serv Res. 2020 Jan 31;20(1):73
pubmed: 32005232
Prof Nurse. 2003 Aug;18(12):694-7
pubmed: 12955942
Int J Integr Care. 2021 Feb 25;21(1):8
pubmed: 33664641
Curr Oncol. 2022 Feb 17;29(2):1201-1212
pubmed: 35200601
JBI Evid Synth. 2020 Jun;18(6):1285-1291
pubmed: 32813376
JCO Oncol Pract. 2021 Sep;17(9):e1311-e1317
pubmed: 33621118
JMIR Res Protoc. 2021 Sep 10;10(9):e26220
pubmed: 34387553
BJS Open. 2020 Apr;4(2):260-267
pubmed: 32003132
Intern Med J. 2012 Nov;42(11):1213-8
pubmed: 22530597
Br J Oral Maxillofac Surg. 2021 Dec;59(10):1248-1252
pubmed: 34417075
BJU Int. 2021 Sep;128(3):271-279
pubmed: 34028162
Cancer Med. 2023 Apr;12(7):8729-8741
pubmed: 36647755
BMJ Open. 2021 Dec 9;11(12):e050139
pubmed: 34887273
JCO Oncol Pract. 2022 Oct;18(10):691-693
pubmed: 36049149
JMIR Form Res. 2021 Mar 5;5(3):e25220
pubmed: 33646965
Australas Radiol. 2004 Dec;48(4):487-92
pubmed: 15601329
Br J Cancer. 2020 Sep;123(5):698-699
pubmed: 32704177
Cancers (Basel). 2021 Aug 18;13(16):
pubmed: 34439312
Syst Rev. 2018 Mar 27;7(1):49
pubmed: 29580293
Cancer Med. 2022 May;11(9):1965-1971
pubmed: 35257515
J Med Internet Res. 2020 Nov 6;22(11):e22280
pubmed: 33079693
Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006632
pubmed: 20238347
J Glob Oncol. 2018 Sep;4:1-7
pubmed: 30241204
BMC Med. 2016 Feb 23;14:35
pubmed: 26904977
Ann Surg Oncol. 2011 Aug;18(8):2116-25
pubmed: 21442345
Br J Cancer. 1994 Aug;70(2):363-70
pubmed: 8054286
Am J Clin Pathol. 2021 Mar 15;155(4):615-616
pubmed: 33382874
Cancers (Basel). 2021 Nov 17;13(22):
pubmed: 34830901
BMC Musculoskelet Disord. 2021 Jan 5;22(1):18
pubmed: 33402136
BMC Med Educ. 2022 Jun 27;22(1):502
pubmed: 35761247
Br J Cancer. 2013 Jun 25;108(12):2433-41
pubmed: 23756866
BMC Health Serv Res. 2022 Jun 27;22(1):829
pubmed: 35761282
Med Oncol. 2018 Nov 13;36(1):2
pubmed: 30426243
Clin Oral Investig. 2022 Mar;26(3):2937-2948
pubmed: 34792667
JCO Oncol Pract. 2022 Oct;18(10):e1603-e1610
pubmed: 35939774
J Multidiscip Healthc. 2022 Oct 21;15:2421-2430
pubmed: 36304726
Eur Radiol. 2023 Feb;33(2):1194-1204
pubmed: 35986772
Public Health Pract (Oxf). 2020 Nov;1:100047
pubmed: 34173579
Pan Afr Med J. 2011;9:20
pubmed: 22355430
J Am Coll Surg. 2013 Sep;217(3):412-20
pubmed: 23891067
BMJ Open. 2019 Nov 7;9(11):e028609
pubmed: 31699717
Front Oncol. 2021 Mar 08;11:630906
pubmed: 33763367
Cancers (Basel). 2022 Aug 12;14(16):
pubmed: 36010898